Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
The Captial Market (CapitalMarket.com) rating for Sagility India IPO is 38. Their analysis recommends Do Not Subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 38 | Do Not Subscribe |
[Dilip Davda] The company specialized health care related technology enabled solutions and services provider to US and other advanced countries. It posted steady growth for FY22 to FY24. Based on annualized FY25, the issue appears aggressively priced. Considering its track records and the future prospects, it is pure long term story. Well-informed/cash surplus investors may park funds for long term. Read detail review...
Sagility India IPO Reviews, analysis and views by popular members. Read Sagility India Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP